Why Is Jazz (JAZZ) Down 1.5% Since Last Earnings Report?
nasdaq.com
news
2022-06-03 11:32:00

A month has gone by since the last earnings report for Jazz Pharmaceuticals (JAZZ). Shares have lost about 1.5% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Jazz due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.

Jazz Pharmaceuticals Q1 Earnings and Sales Miss Estimates

Jazz Pharmaceuticals reported adjusted earnings of $3.
